Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Meningococcal polysaccharide vaccine groups A C Y W135 - Bio-Med

Next Previous
Drug Profile

Meningococcal polysaccharide vaccine groups A C Y W135 - Bio-Med

Alternative Names: Meningococcal Polysaccharide Vaccine (Group A, C, Y and W135) - Bio Med; Quadri Meningo

Latest Information Update: 09 Mar 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bio-Med
  • Class Antibacterials; Meningococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Meningococcal infections

Most Recent Events

  • 09 Mar 2021 Meningococcal polysaccharide vaccine groups A C Y W135 is still in phase III trial for Meningococcal infections (Prevention) in South America, North America, Europe, Japan, Australia, Africa, Asia (IM) (SC)
  • 09 Mar 2021 Bio-Med completes a phase III trial for Meningococcal infections (Prevention) in South America, North America, Europe, Japan, Australia, Africa, Asia (IM) (SC) before March 2021 (UMIN000034298)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top